Skip to main content
Fig. 3 | Reproductive Biology and Endocrinology

Fig. 3

From: Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection

Fig. 3

Pregnancy and live birth outcomes. Note: hCG: human chorionic gonadotrophin.aRates are calculated per treatment group as the percentage of women in the FAS. The retrieved rate was defined as women with at least one oocyte retrieved. bThe transfer rate was defined as percentage of women with embryo transfer. cβhCG rate was defined as percentage of women with a positive test of serum βhCG 2 weeks after transfer. dClinical pregnancy rate was defined as percentage of women with at least one gestational sac 5–6 weeks after transfer. eVital pregnancy rate was defined as percentage of women with at least one intrauterine gestational sac with fetal heart after transfer. fOngoing pregnancy rate was defined as percentage of women with at least one intrauterine viable fetus 10–11 weeks after transfer. gLive birth rate was defined as percentage of women with birth of at least one live-born neonate. hLive birth rate at 4 weeks after birth was defined as percentage of women with at least one live neonate 4 weeks after birth

Back to article page